This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chavez-Bueno, S.
Right arrow Articles by Appelbaum, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chavez-Bueno, S.
Right arrow Articles by Appelbaum, P. C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2005, p. 2283-2288, Vol. 49, No. 6
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.6.2283-2288.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Inducible Clindamycin Resistance and Molecular Epidemiologic Trends of Pediatric Community-Acquired Methicillin-Resistant Staphylococcus aureus in Dallas, Texas

Susana Chavez-Bueno,1* Bülent Bozdogan,2,{dagger} Kathy Katz,1 Karen L. Bowlware,1,{ddagger} Nancy Cushion,1 Dominick Cavuoti,3 Naveed Ahmad,3 George H. McCracken Jr.,1 and Peter C. Appelbaum2

University of Texas Southwestern Medical Center of Dallas,1 Children's Medical Center of Dallas, Dallas, Texas 75390,3 Hershey Medical Center, Hershey, Pennsylvania 170332

Received 21 October 2004/ Returned for modification 26 December 2004/ Accepted 30 January 2005

Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infection occurs commonly in children. Clindamycin resistance may be inducible or constitutive, and the rates of inducible resistance in CA-MRSA that could produce clindamycin treatment failures vary worldwide. The double-disk test was performed in 197 erythromycin-resistant and clindamycin-susceptible CA-MRSA strains from children in Dallas, Texas, from 1999 to 2002 to determine inducible clindamycin resistance. Resistance mechanisms were studied by PCR; epidemiologic trends were studied by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). Inducible resistance was demonstrated in 28 (93% ±6%) of 30 tested isolates in 1999, 21 (64%, ±11%) of 33 in 2000, 12 (23% ±7%) of 52 in 2001, and 6 (7% ±3%) of 82 in 2002. All noninducible strains had the msr(A) gene. Among inducible resistant strains, 31 had erm(B), 24 had erm(C), and 12 had erm(A) genes. Two distinct pulsed types were the most prevalent; one of them was the most common pulsed type in 1999, whereas in 2002 a different pulsed type was prevalent. MLST analyses determined that ST-8 was the most common type, with 76% ±5% found in 2002. All but one of these clindamycin-susceptible, erythromycin-resistant ST-8 strains showed no induction of clindamycin resistance. We conclude that, among erythromycin-resistant, clindamycin-susceptible CA-MRSA strains isolated from children in Dallas, inducible methylase resistance became less common from 1999 to 2002 (P < 0.001). The phenotype of strains was associated with their sequence type. Our results demonstrate a clonal shift in CA-MRSA in Dallas children from 1999 to 2002.


* Corresponding author. Mailing address: 5323 Harry Hines Boulevard, Dallas, Texas 75390-9063. Phone: (214) 648-3720. Fax: (214) 648-2961. E-mail: Susana.Chavez-Bueno{at}UTSouthwestern.edu.

{dagger} Present address: Institut Pasteur, 75015 Paris, France.

{ddagger} Present address: University of Oklahoma, Health Sciences Center, Oklahoma City, OK 73104.


Antimicrobial Agents and Chemotherapy, June 2005, p. 2283-2288, Vol. 49, No. 6
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.6.2283-2288.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Luna, V. A., Xu, Z.-Q., Eiznhamer, D. A., Cannons, A. C., Cattani, J. (2008). Susceptibility of 170 isolates of the USA300 clone of MRSA to macrolides, clindamycin and the novel ketolide cethromycin. J Antimicrob Chemother 62: 639-640 [Full Text]  
  • Jung, Y.-H., Kim, K. W., Lee, K. M., Yoo, J. I., Chung, G. T., Kim, B. S., Kwak, H.-S., Lee, Y. S. (2008). Prevalence and characterization of macrolide-lincomycin-streptogramin B-resistant Staphylococcus aureus in Korean hospitals. J Antimicrob Chemother 61: 458-460 [Full Text]  
  • Depardieu, F., Podglajen, I., Leclercq, R., Collatz, E., Courvalin, P. (2007). Modes and Modulations of Antibiotic Resistance Gene Expression. Clin. Microbiol. Rev. 20: 79-114 [Abstract] [Full Text]  
  • O'Sullivan, M. V. N., Cai, Y., Kong, F., Zeng, X., Gilbert, G. L. (2006). Influence of Disk Separation Distance on Accuracy of the Disk Approximation Test for Detection of Inducible Clindamycin Resistance in Staphylococcus spp.. J. Clin. Microbiol. 44: 4072-4076 [Abstract] [Full Text]  
  • Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., Talan, D. A., the EMERGEncy ID Net Study Group, (2006). Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department.. NEJM 355: 666-674 [Abstract] [Full Text]  
  • Patel, M., Waites, K. B., Moser, S. A., Cloud, G. A., Hoesley, C. J. (2006). Prevalence of Inducible Clindamycin Resistance among Community- and Hospital-Associated Staphylococcus aureus Isolates.. J. Clin. Microbiol. 44: 2481-2484 [Abstract] [Full Text]  
  • Tenover, F. C., McDougal, L. K., Goering, R. V., Killgore, G., Projan, S. J., Patel, J. B., Dunman, P. M. (2006). Characterization of a Strain of Community-Associated Methicillin-Resistant Staphylococcus aureus Widely Disseminated in the United States. J. Clin. Microbiol. 44: 108-118 [Abstract] [Full Text]  
  • O'Brien, F. G., Zaini, Z., Coombs, G. W., Pearson, J. C., Christiansen, K., Grubb, W. B. (2005). Macrolide, lincosamide and streptogramin B resistance in a dominant clone of Australian community methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 56: 985-986 [Full Text]